https://www.healthcentral.com/article/new-abuseresistant-oxycodone-gets-fda-approval
Health A-Z
Ask a question
Health Central
    • Healthy Living
      • Food & Nutrition
      • Fitness & Exercise
      • Children's Health
      • Men's Health
      • Women's Health
      • Healthy Aging
    • Resources
      • Encyclopedia
      • News
      • Newsletters
  • Health Conditions & Topics
    • ADHD
    • Allergies
    • Alzheimer's Disease
    • Arthritis & Joints
    • Asthma
    • Bipolar Disorder
    • Brain & Nerve Health
    • COPD
    • Crohn's Disease
    • Dementia
    • Dental Health
    • Depression
    • Diabetes
    • Digestive Health
    • Erectile Dysfunction
    • GERD
    • Health Care & Insurance
    • Heart Health
    • Hepatitis C
    • High Cholesterol
    • Incontinence
    • Infectious Diseases
    • Lung & Respiratory
    • Menopause
    • Mental Health
    • Migraine
    • Multiple Sclerosis
    • Obesity
    • Pain Management
    • Pregnancy & Fertility
    • Prostate Health
    • Psoriasis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Skin Health
    • Sexual Health
    • Sleep Disorders
    • Thyroid Health
    • Ulcerative Colitis
    • Vision Health
  • Cancer Care
    • Cancer
    • Brain Cancer
    • Breast Cancer
    • Colon Cancer
    • Lung Cancer
    • Multiple Myeloma
    • Ovarian Cancer
    • Prostate Cancer
    • Skin Cancer
    • Stomach Cancer

Pain Management

Also See Addiction | Multiple Sclerosis | Rheumatoid Arthritis | Mental Health
Get Our Newsletters Share Your Story

New Abuse-Resistant Oxycodone Gets FDA Approval

Karen Lee Richards , Patient Expert

Yesterday Pfizer, Inc. and Acura Pharmaceuticals, Inc. announced they had received marketing approval from the FDA for Oxecta, a new abuse-resistant formulation of immediate-release oxycodone.   Oxycodone is an opioid analgesic used for the management of both acute and chronic moderate to severe pain.

Oxecta is the first immediate-release oxycodone medicine that applies technology designed to discourage common methods of tampering associated with opioid abuse and misuse.   This technology, known as Aversion® Technology, uses a unique composition of commonly used pharmaceutical ingredients that prevent the medicine from being dissolved or crushed for the purpose of abusing them.   Pfizer is licensing the technology in Oxecta from Acura.

In their press release, the companies noted, "Opioid medications are an important treatment option for patients with moderate to severe pain who are not adequately managed by other pain treatments. However, abuse and misuse of opioids is a serious public health issue that is the focus of a number of recent United States government initiatives."

Oxecta should not be taken by persons with severe respiratory problems.   The most common adverse reactions are nausea, constipation, vomiting, headache, itchiness, trouble sleeping, dizziness, loss of strength/energy, and sleepiness.   For more details about important safety information, read the full Oxecta press release.

Karen is the Co-Founder of the National Fibromyalgia Association. She wrote for HealthCentral as a patient expert for Pain Management.

Published On: June 21, 2011
Traditional Chinese Medicine Could Benefit TMD Patients
Traditional Chinese Medicine Could Benefit TMD Patients
13 Sizzling Questions on Marijuana 13 Sizzling Questions on Marijuana
10 Causes of Low Back Pain
The 9 Best Treatments for Sciatic Nerve Pain

© 2018 Remedy Health Media, LLC All rights reserved

  • About Us
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Security Policy
  • Advertise With Us
  • Our Sites
  • The Body
  • The Body Pro
  • Berkeley Wellness
  • Health Communities
  • Intelecare
  • Mood 24/7